Heartburn efficacy study
This article was originally published in The Tan Sheet
Executive Summary
Out of nearly 2,000 study participants and GERD sufferers in Europe and the U.S., those who took prescribed proton pump inhibitors were more likely to have improved symptoms than those whose symptoms were undiagnosed and took OTC remedies, according to a study presented during Digestive Disease Week May 14-19 in Chicago. Roger Jones, Guy's King's and St. Thomas School of Medicine, et al., used a 100-item questionnaire to identify participants. "Of undiagnosed sufferers taking OTC medicines, 81% still suffered some symptoms compared with 68% of diagnosed patients taking prescription drugs and 69% of diagnosed patients taking PPIs," the study states. Astrazeneca, marketer of prescription Nexium, provided funding for the study...